Bruker (NASDAQ: BRKR) reported Q2 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $371.7 million versus the consensus estimate of $410.39 million.

GUIDANCE:

Bruker sees FY2016 EPS of $0.97-$1.02, versus the consensus of $1.01.

For earnings history and earnings-related data on Bruker (BRKR) click here.